Protalix BioTherapeutics, Inc.
PLX · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $3 | $8 | -$15 | -$28 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | -$3 | $0 | $0 |
| Stock-Based Comp. | $3 | $3 | $2 | $2 |
| Change in WC | $1 | -$11 | -$12 | $10 |
| Other Non-Cash | $0 | -$1 | -$1 | $4 |
| Operating Cash Flow | $9 | -$1 | -$25 | -$10 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$1 | -$1 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$15 | -$20 | -$16 | -$38 |
| Inv. Sales/Matur. | $20 | $5 | $11 | $58 |
| Other Inv. Act. | $0 | -$0 | $1 | $0 |
| Investing Cash Flow | $4 | -$17 | -$5 | $19 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$20 | $0 | $0 | -$34 |
| Stock Issued | $4 | $24 | $8 | $46 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $1 | $0 | $0 |
| Financing Cash Flow | -$17 | $25 | $8 | $12 |
| Forex Effect | $0 | -$0 | -$0 | $0 |
| Net Chg. in Cash | -$4 | $7 | -$22 | $21 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $24 | $17 | $39 | $18 |
| End Cash | $20 | $24 | $17 | $39 |
| Free Cash Flow | $7 | -$2 | -$26 | -$12 |